¿Cómo se comparó el EPS reciente de ASBP con las expectativas?
¿Cómo fue el desempeño de los ingresos de Aspire Biopharma Holdings Inc ASBP en el último trimestre?
¿Cuál es la estimación de ingresos para Aspire Biopharma Holdings Inc?
¿Cuál es la puntuación de calidad de ganancias de Aspire Biopharma Holdings Inc?
¿Cuándo informa Aspire Biopharma Holdings Inc sus ganancias?
¿Cuáles son las ganancias esperadas de Aspire Biopharma Holdings Inc?
¿Superó Aspire Biopharma Holdings Inc las expectativas de ganancias?
Estadísticas clave
Cierre Anterior
$1.46
Precio de apertura
$1.43
Rango del día
$1.36 - $1.48
Rango de 52 semanas
$1.26 - $632
Volumen
133.8K
Volumen promedio
1.3M
EPS (TTM)
-1.65
Rendimiento de dividendos
--
Cap. de mercado
$152.6M
¿Qué es ASBP?
Aspire Biopharma Holdings Inc is a PR-based company operating in Pharmaceuticals industry. Aspire Biopharma Holdings, Inc. is an early-stage biopharmaceutical company. The company develops and markets a technology for novel delivery mechanisms for FDA approved drugs, nutraceuticals, and supplements. The company has developed and acquired technologies that are a Novel Soluble Formulation which address emergencies and drug efficacy, dosage management, and response time. Its Sublingual Aspirin Product, which addresses cardiology emergencies and pain management, is a granular or powder formulation of a soluble, Ph-neutral, fast-acting aspirin. The company also has numerous pharmaceutical and nutraceutical applications under development in various areas, including but not limited to a Viagra/Cialis combination product which is faster acting, requiring decreased dosages with the benefit of a longer half-life, various bi-hormonal drugs such as testosterone, estrogen and weight loss drugs, and thyroid drugs, as well as various supplements including a rapid-absorbing pre-workout and a melatonin sleep aid.